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Abstract
Precise regulation of epidermal growth factor (EGF) receptor (EGFR) activated sig-
naling pathways is essential in cell fate decisions. Recent experiments observe
change in EGFR internalization route from clathrin mediated (CME) to clathrin
independent endocytosis (CIE) with rising EGF concentration, which alters the re-
ceptor localization and modulates associated signaling. The regulatory mechanism
controlling the shift in endocytosis remains unknown. In this study, we present a
novel mathematical model that describes the dose dependent regulation of EGFR
trafficking through receptor ubiquitination. We assume that the receptor-ubiquitin
binding reaction follows a sigmoidal behavior as function of EGF dose, which is
responsible for a switch-like activation of CIE. Using the model we illustrate the
change in the EGFR localization as function of EGF dose and route of endocytosis.
The model is further utilized to explore the effect of defective ubiquitination on the
EGFR trafficking. At high EGF concentrations, model results quantitatively cap-
ture experimentally observed changes in receptor localization caused by selective
inhibition of CME or CIE. These results elucidate the ubiquitin guided sorting of
EGFR during internalization. In agreement with experiments for low EGF dose, our
model predicts that CIE remains largely inactive causing prolonged EGFR transport
and decreased ligand degradation and strengthens our assumption of ultrasensitive
receptor-ubiquitin binding. Our model accurately captures the experimentally ob-
served deregulation in EGFR trafficking resulting from mutation induced defective
ubiquitination and demonstrates the importance of receptor ubiquitination. The
predictions obtained clearly indicate that our model successfully captures the un-
derlying dynamics of ubiquitin regulated EGFR sorting and trafficking and provides
valuable insights into the experimental observations. The model may thus provide
a framework to study the dose-dependent attenuation of EGFR activated signaling
pathways.
Zusammenfassung
Die pra¨zise Regulierung der Signalwege, die vom epidermalen Wachstumsfaktor
(EGF)-Rezeptor (EGFR) angeregt werden, ist von wesentlicher Bedeutung fu¨r Entschei-
dungen u¨ber das Zellschicksal. In ju¨ngsten Experimenten wurde beobachtet, dass
die Internalisierung von EGFRmit steigender EGF-Konzentration von der Clathrin-
vermittelten (CME) zu Clathrin-unabha¨ngiger Endozytose (CIE) wechselt, was mit
A¨nderungen der Rezeptorlokalisation einhergeht und die damit verbundenen Sig-
nale moduliert. Der Regulationsmechanismus, welcher diese Verschiebung der En-
dozytose steuert, ist bisher nicht bekannt. In dieser Studie pra¨sentieren wir ein
neues mathematisches Modell, das die dosisabha¨ngige Regulierung des EGFR-
Transports durch Rezeptor-Ubiquitinierung beschreibt. Wir nehmen an, dass die
Rezeptor-Ubiquitin-Bindungsreaktion einer sigmoidalen Funktion der EGF-Dosis
folgt, welche als Schalter fu¨r die Aktivierung der CIE wirkt. Mithilfe dieses Mod-
ells zeigen wir die A¨nderung in der EGFR-Lokalisation als Funktion der EGF-Dosis
und der Art der Endozytose. Weiterhin benutzen wir das Modell, um die Wirkung
gesto¨rter Ubiquitinierung auf den EGFR-Transport zu untersuchen. Bei hohen
EGF-Konzentrationen, zeigen die Modellergebnisse quantitative U¨bereinstimmung
mit experimentell beobachteten Vera¨nderungen in Rezeptorlokalisation, die durch
selektive Hemmung von CME oder CIE verursacht wird, und unterstreichen damit
die Ubiquitin-gesteuerte Sortierung des EGFR. In U¨bereinstimmung mit den Ex-
perimenten fu¨r niedrige EGF-Dosis, sagt unser Modell voraus, dass CIE weit-
gehend inaktiv bleibt und damit verla¨ngerten EGFR-Transport und verringerten
Ligandenabbau verursacht. Dies unterstu¨tzt unsere Annahme der ultrasensitiven
Rezeptor-Ubiquitin-Bindung. Unser Modell erfasst die experimentell beobachtete
Deregulierung des EGFR-Transports durch mutationsinduzierte, defekte Ubiqui-
tinierung pra¨zise, und zeigt damit die Bedeutung der Rezeptor-Ubiquitinierung. Die
gewonnenen Vorhersagen zeigen deutlich, dass unser Modell in der Lage ist, die zu-
grunde liegende Dynamik der Ubiquitin-regulierten Sortierung und Transport des
7EGFR zu erfassen, und liefern eine wertvolle Interpretation der experimentellen
Beobachtungen. Das Modell kann somit einen Rahmen fu¨r die Untersuchung der
dosisabha¨ngigen Da¨mpfung der EGFR-aktivierten Signalwege bieten.
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Chapter 1
Introduction
Cells interact with extracellular stimulus through the membrane bound receptors
such as receptor tyrosine kinases (RTKs). These receptors upon binding with the
ligand turn active and initiate cascade of signaling pathways. Through the signal-
ing pathways information is transferred and encoded to generate stimuli specific
responses. Post binding receptors are internalized and transported across the intra-
cellular compartments. From the inside of a cell, receptors activate a different set
of cellular signaling leading to different outcome. These features of the RTK acti-
vation and transport are fundamental to cellular response and adaptation. A class of
RTKs belonging to the family of ErbB plays pivotal role in cell cycle. ErbB family
consists of four receptors namely ErbB1, ErbB2, ErbB3, and ErbB4. Upon binding
with specific ligand, receptor sends an input signal which is processed downstream
to produce distinct outputs ranging from cell division and migration to adhesion,
differentiation and apoptosis (Figure: 1.1). Hence, function of ErbB activated sig-
naling is extremely important in human cancers and other cell cycle related diseases.
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The epidermal growth factor receptor (EGFR) orchestrates a cascade of intra-
cellular signaling crucial in cell growth, survival, proliferation and cell differentia-
tion (Oda et al., 2005). It is responsible for the activation of signaling pathways at
cell surface as well as inside of the cell (Sorkin and von Zastrow, 2009). At the cell
surface, EGFR works as a sensor of the extracellular stimuli and across the intracel-
lular compartments as a carrier of stimulating ligand. Various growth factors bind
to the EGFR and form a receptor-ligand complex triggering a series of signaling
events at the cell membrane. These complexes then internalize through different
modes of endocytosis (Mayor and Pagano, 2007; Orth et al., 2006; Sorkin and Goh,
2008). Inside a cell, specific signaling pathways are activated and deactivated de-
pending on the localization of receptors (Murphy et al., 2009). Therefore, accurate
intracellular positioning of the receptors is essential in modulating cellular signal-
ing. Any error in localization of EGFRs and/or ligands leads to the dysfunction
of cellular signaling and may bring a cell on the verge of cancer (Yarden and Sli-
wkowski, 2001). Cells regulate EGF induced signaling in a dose dependent fashion
through systematic regulation of the EGFR trafficking. Yet, the mechanism gov-
erning trafficking and localization of EGFR remains unknown, leaving a gap in the
understanding of dose-dependent regulation in EGF induced signaling.
Post EGF binding, EGFR undergoes further modification through binding
of single or multiple ubiquitin molecules (Dikic et al., 2009). Free ubiquitin is at-
tached to its substrates through an E1-E2-E3 multi-enzyme cascade (Dikic et al.,
2009; Weissman, 2001; Ye and Rape, 2009). In case of EGFR, Cbl ligase (an E3
enzyme) attaches itself to the EGF-EGFR complex and guides the binding of one
or several ubiquitin molecules. This attachment of ubiquitin can affect localiza-
tion, activity, and interaction partners of the ubiquitinated receptors (Woelk et al.,
2007). Various experiments show that ubiquitination plays an important role in en-
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dosomal sorting as it labels ubiquitinated receptors for lysosomal degradation thus
reducing recycling of the receptors (Haglund et al., 2003; Weissman, 2001). Hence,
ubiquitination works as a negative regulator of signaling (Dikic, 2003; Duan et al.,
2003). Studies show receptor modification by ubiquitin is a signal for initiation of
endocytosis. Experiments also show plausible internalization of receptors without
ubiquitin binding (Huang et al., 2007). Another experimental study suggests a link
between external EGF concentration and the extent of EGFR ubiquitination (Sigis-
mund et al., 2005). In the study, data show negligible EGFR ubiquitination for
low EGF dose, however, amount of EGFR ubiquitination is significant at high EGF
concentration. This behavior is seen as a sigmoidal response in receptor-ubiquitin
binding as a function of EGF dose (Acconcia et al., 2009).
Internalization of receptor from cell surface is a key step that regulates entire
EGFR trafficking. Through endocytic routes, ligand bound EGFR travels from the
cell membrane to cytoplasm. In clathrin-mediated endocytosis (CME), ligand re-
ceptor binding initiates formation of clathrin-coated pits that collect ligand-receptor
complexes from the cell membrane. The coated pits detach from the membrane as
clathrin-coated vesicles and transport the ligand-receptor complexes to early endo-
somes. However, many studies provide evidence that in parallel with CME, recep-
tors can also internalize through clathrin independent mode of endocytosis (Mayor
and Pagano, 2007; Orth et al., 2006). The clathrin independent route of endocytosis
exploits cholesterol-rich membrane domains (i.e., rafts and caveolin) (Aguilar and
Wendland, 2005; Mayor and Pagano, 2007). Considering the limitations in under-
standing the molecular nature of clathrin independent endocytosis (CIE), we define
the process as a mode of endocytosis alternative to the CME, which is uninfluenced
by the ablation of clathrin. In addition, drugs that interact with membrane choles-
terol reducing membrane flexibility such as Filipin can impair CI internalization.
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Sigismund et al. (2008) show that EGFR uses CME or both CME and CIE routes
depending on the extracellular concentration of EGF. At low concentration of EGF,
Sigismund et al. observe only CME to be active whereas at high concentration of
EGF both CME and CIE modes are active. Interestingly, the same study shows
that receptor and ligand undergo different fate based on their mode of endocytosis.
Experiments show receptors entering through CME are more favored for recycling
and less for degradation; conversely, those entering through CIE are more prone
to degradation and less to recycling. These findings provide evidence that EGFR
trafficking is regulated in response to a changing external ligand concentration.
From the experimental observations, it can be interpreted that a majority
of ubiquitin-free EGFRs use CME while majority of ubiquitin-bound EGFRs en-
ter through CIE mode. Hence, receptor ubiquitination functions as a regulatory
step controlling the EGFR internalization routes in EGF dose-dependent manner.
We infer this as a new hypothesis for an EGF dose-dependent regulation of EGFR
trafficking. Wherein, at low EGF concentration due to insignificant ubiquitina-
tion of EGFR, CIE route remains largely inactive and entry through CME is domi-
nant. This leads to low degradation and high recycling EGFR providing a sustained
signaling. However, at high EGF level, elevated ubiquitination of EGFR initiates
clathrin independent (CI) internalization. This significantly reduces EGFR count
due to an overall increase in degradation of EGFR concluding in the termination of
trafficking and associated signaling.
Several existing computational studies help to unravel different aspects of
the dynamics of ligand induced EGFR trafficking and consequent signaling. These
studies levy emphasis on modeling the ligand-receptor interaction and internaliza-
tion (Starbuck and Lauffenburger, 1992; Waters et al., 1990; Wiley and Cunning-
ham, 1981). In order to study the EGFR intracellular trafficking, early experimental
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studies used high EGF concentrations due to technical limitations in data acquisi-
tion. Hence, models developed to explain these experimental data are more suitable
for the condition of high EGF. Additional experimental data gathered from intra-
cellular compartments and the extension of initial models provide a quantitative de-
scription of the intracellular EGFR trafficking (French et al., 1994, 1995). Further
advances in the experimental techniques provided details about the EGFR associ-
ated signaling. Recent models developed using the principles of chemical kinetics
are able to explain the cellular signaling that arises post ligand-receptor binding
(Kholodenko et al., 1999; Resat et al., 2003). These theoretical studies provide
valuable insights into the nature of signaling and its complexity.
Most of the published models assume a single mode of endocytosis in de-
scribing the receptor internalization. This restricts the possibility of studying the
influence of different modes of endocytosis on the EGFR trafficking and signaling.
In these studies, ubiquitin-bound or ubiquitin-free receptor populations are indis-
tinct. Lund et al. (1990) propose that ligand-bound receptors internalize through
clathrin coated pits whereas empty receptors use non-coated pits (smooth pits). The
model by Lund et al., excludes the clathrin independent internalization of ligand-
bound EGFR and receptor ubiquitination. Thus, the role of CIE and ubiquitination
remains unclear. A recently published computational study models a signaling net-
work activated simultaneously by members of ErbB receptor family (Chen et al.,
2009). Their study encompasses key components of the signaling that become ac-
tive in immediate response to the receptor phosphorylation. Chen et al. use a set
of 499 ordinary differential equations to study time evolution of 471 species of the
huge network. Though their model provides details about the dynamic behavior
of the signaling cascades with respect to time and EGF concentration, it excludes
the components required for ubiquitination and CIE mode. Thus, effect of recep-
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tor ubiquitination and CIE mode on the receptor trafficking remains unexplored.
Another modeling study proposes that at high EGF dose, saturation of CME route
activates the CIE generating an ultrasensitive surface sorting of EGFR (Schmidt-
Glenewinkel et al., 2008). The assumptions made by the authors appear inconsis-
tent with recent experimental observations this leaves their proposed mechanism
unconfirmed. Although various experimental studies and existing mathematical
models provide a great deal of information about EGFR trafficking, the regulation
of EGFR transport by means of ubiquitination and clathrin independent internal-
ization, a cause and effect dynamics, however remains poorly understood. Insights
into EGFR trafficking and its regulation are of foremost importance in order to an-
alyze the dose-dependent attenuation of signaling pathways.
In this report, we present a mathematical model to study the role of ubiquiti-
nation and CIE mode in EGFR trafficking. To elucidate the effect of ubiquitination,
our model considers two sub-populations of ligand-receptor complexes: ubiquitin-
free and ubiquitin-bound complexes. The model also accounts for existence of
CME and CIE as two different modes of endocytosis. We fit the model with exper-
imental data to validate it and identify model parameters. We study the impact of
CME/CIE inhibition and influence of EGF dosage on the EGFR trafficking. Fur-
ther, we utilize the model to predict the effect of defective receptor ubiquitination
on the dynamics of EGFR transport. The information provided by our model is ex-
tremely useful in understanding the modulation of cellular signaling with varying
ligand concentration vis-a´ -vis cellular adaptation in a changing environment.
Chapter 2
Model development
2.1 Model formulation
Scope of our model is to study the influence of receptor ubiquitination, in response
to the changing environment, on the localization of EGFR at the cell surface and
inside endosome. Using the model, we aim to explore the implications of defects in
regulation of EGFR trafficking introduced by selectively disrupting internalization
routes. To construct a basic framework for the model we use information from var-
ious modeling and experimental studies. We write model equations assuming mass
action kinetics for reactions and for the transport and internalization are first order
processes. Figure 2.1 depicts the proposed EGF stimuli dependent receptor ubiq-
uitination, EGFR internalization, and intracellular transport. Figure 2.2 presents
the flow diagram of the EGFR trafficking events. At the cell surface, a reversible
binding between EGF (Lm) and its receptor (Rs) forms a ligand-receptor complex
(Cs). In line with the existing models, we assume activation of receptor to be spon-
taneous and ligand-receptor complex to be active on ligand binding. Unlike other
studies in our model, for ligand-receptor complex we propose two modes of endo-
8
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Figure 2.1: Pictorial representation of proposed EGFR surface sorting and traffick-
ing.
cytosis: clathrin dependent (CME) and clathrin independent (CIE). We assume that
ubiquitin-free complexes enter through CME route. Considering the recent exper-
imental observations (Sigismund et al., 2005), we propose that extent of receptor
ubiquitination is dependent on the amplitude of EGF stimuli. Literature suggests
that receptor ubiquitination displays sigmoidal behavior in response to the level
EGF dose (Acconcia et al., 2009). However, the exact mechanism responsible for
a switch like response remains unclear. To overcome this limitation we assume rate
of receptor ubiquitination to be a function of EGF dose. We relate ubiquitination
rate constant and level of EGF stimuli using Hill kinetics to reproduce the proposed
ultrasensitivity in extent of ubiquitin-complex binding. An approximate value for
the Hill coefficient (nH) can be obtained from the EGF concentration values used
in experiments (as shown in the following section). In the model, we consider that
formation of ubiquitin bound complex (Cu) activates the CIE route and these ubiq-
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Figure 2.2: Flowchart depicting the proposed reactions and transport events during
the EGFR trafficking. Letters in the boxes are variable names as used in the model
equations (Table 2.1). Fraction of a population that undergoes recycling (green line)
and degradation (blue line) corresponds to thickness of the line.
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uitinated receptors-complexes use the CIE mode for internalization.
Using the respective route of endocytosis, both ubiquitin-free complexes
(Cic) and ubiquitin-bound complexes (Cin) reach the endosomal compartment. In-
side the endosome ligand-receptor complex (Cec and Cen) is recycled or dissociates
giving ligand free receptor and free ligand. The ligand free receptors and free ligand
are sorted for recycling and degradation (Rdc, Rdn, Ldc, & Ldn). It is evident from
various experimental studies that ubiquitin-bound receptors are targeted for lysoso-
mal degradation (Duan et al., 2003; Peschard and Park, 2003). Hence, ubiquitin-
bound complexes internalizing through CIE mode are assumed to be more prone
for degradation and only a small portion of these complexes (Cen), receptors (Ren),
and their ligands (Len) is recycled. Before the degradation of these receptors, ubiq-
uitin molecules dissociate and recycle back to the cell membrane. Experimental
evidence suggest that ubiquitin defective receptors are less likely to degrade and
show an enhanced recycling (Peschard and Park, 2003). Thus, we suspect that a
major faction of ubiquitin-free complexes (Cec), receptors (Rec) and their ligands
(Lec) to be recycled and reminder is degraded.
2.1.1 Model equations
We write model equations assuming mass action kinetics for reactions and for
the transport and internalization are first order processes. We assume amount ubiq-
uitin molecules to be present in abundance compared to ligand-receptors and the
amount of ubiquitin remains constant due to recycling. Thus, we consider receptor
ubiquitination to be first order reaction. We propose that value of rate constant for
ubiquitin binding reaction to be a function of extracellular ligand concentration.
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Model equations representing reactions at the cell surface:
VxNav
dLm
dt
= −kbLmRs + kubCs + klcLec + klnLen (2.1)
dRs
dt
= −kbLmRs + kubCs + krcRec + krnRen (2.2)
dCs
dt
= kbLmRs − kubCs − kecCs − ku
(
LnHm
1 + LnHm
)
Cs + krcCec (2.3)
dCu
dt
= ku
(
LnHm
1 + LnHm
)
Cs − kenCu + krnCen (2.4)
Intracellular compartment:
dCic
dt
= kecCs − keeCic (2.5)
dCin
dt
= kenCu − keeCin (2.6)
Endosomal compartment:
dCec
dt
= keeCic − kebCec +
keubRecLec
NavVe
− krcCec (2.7)
dCen
dt
= keeCin − kebCen +
keubRenLen
NavVe
− krnCen (2.8)
dRec
dt
= kebCec −
keubRecLec
NavVe
− krcRec − krdcRec (2.9)
dRen
dt
= kebCen −
keubRenLen
NavVe
− krnRen − krdnRen (2.10)
dLec
dt
= kebCec −
keubRecLec
NavVe
− klcLec − kdlcLec (2.11)
dLen
dt
= kebCen −
keubRenLen
NavVe
− klnLen − kdlnLen (2.12)
Outside the endosomal compartment:
dRdu
dt
= kdrnRen − kduRdu (2.13)
dRdc
dt
= kdrcRec (2.14)
dRdn
dt
= kduRdu (2.15)
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dLdc
dt
= kdlcLec (2.16)
dLdn
dt
= kdlnLen (2.17)
Model consists of 17 variables and 17 parameters. Table 2.1 provides the list
of all the variables and parameters that are used in the model. Values for the ligand-
receptor binding/unbinding rate constants at cell surface and inside the endosome
are taken from literature (French et al., 1995). The values of endosomal volume
(Ve) used for the model simulation is 10−14 liter/cell (Tzafriri and Edelman, 2007)
and value of extracellular volume (Vx) is 10−10 liter/cell considering the cell popu-
lation range between 106 and 108 cells/ml. We used standard value of Avogadro’s
number (Nav)= 6.0221415×1023. The set of coupled ODEs is solved in MATLAB.
A code is written to solve the model equations to mimic the experimental proto-
cols. Model equations are solved with continuous stimulation of 100 ng/ml EGF
concentration to calculate the surface and total EGFR concentration. To calculate
EGF degradation and recycling the equations are solved with 20 ng/ml EGF for the
pulse phase of 6 min and 15 min, respectively. In order to replicate the chase phase,
we solve the equations with the external EGF concentration and the ligand-bound
receptor population set to zero as initial condition.
2.1.2 Value of Hill coefficient
The Hill equation is commonly used to describe the reaction velocity though its
use can be extended study the nature of stimuli-response curve. Sigmoidal behavior
of a stimuli-response curve can be quantified using Hill coefficient. Higher the value
of the coefficient steeper is the response curve. As common practice coefficient is
estimated by fitting the equation against the stimuli-response data. The coefficient
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Variable Symbol Rate constants Symbol
Ligand in extracellular
medium
Lm Ligand receptor binding and
unbinding rates surface
kb,kub
Receptors at cell surface Rs Ubiquitin binding constant ku
Surface ligand-receptor com-
plex
Cs CME internalization rate kec
Surface ubiquitin-bound
complex
Cu CIE internalization rate ken
Complexes internalizing
through CME route
Cic Rate of transport from sur-
face to endosome
kee
Complexes internalizing
through CIE route
Cin Ligand receptor binding and
unbinding rates in endosome
keb, keub
CME internalized complex in
endosome
Cec Recycling rate of Cec and
Rec
krc
CIE internalized complex in
endosome
Cen Recycling rate of Cen and
Ren
krn
Receptor dissociated from
Cec
Rec Recycling rate of Lec klc
Ligand dissociated from Cec Lec Recycling rate of Len kln
Receptor dissociated from
Cen
Ren Degradation rate of Rec kdrc
Ligand dissociated from Cen Len Deubiquitination rate of Ren kdrn
Deubiquitinated receptor Rdu Degradation rate of Lec kdlc
Degraded receptor CME,
CIE
Rdc, Rdn Degradation rate of Len kdln
Degraded ligand CME, CIE Ldc, Ldn Degradation rate of Rdu kdu
Table 2.1: List of model variables and parameters.
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can be established when data are provided for 10% and 90% response. Goldbeter
and Koshland (1981) derived a correlation between the Hill coefficient and stimuli
concentrations required for 10% and 90% response. The proposed correlations to
calculate Hill coefficient (nH ) is shown below (see also (Huang and Ferrell, 1996))
nH =
log(81)
log(S0.9)− log(S0.1)
(2.18)
where, S0.1 and S0.9 are the stimuli concentrations responsible for generation 10%
and 90% response, respectively.
When the stimuli concentrations are unavailable, the output response can
be used instead. The above correlation then can also be written in terms of the
substrate consumption. In our case, we consider the percentage of total receptor
undergoing ubiquitination to be the marker of output response. The new correlation
can therefore be written as follows:
nH =
log(81)
log(0.9×RT )− log(0.1× RT )
= 2 (2.19)
where, RT is the total EGFR count.
An alternative way to establish the coefficient is as follows.
In the experiments, Sigismund et al. (2008) use two concentrations of EGF
ligand 1.5 ng/ml (low EGF) and 20 ng/ml (high EGF). Their previous study show
for low EGF dose receptor ubiquitination is minimal and significant ubiquitination
for high EGF (Sigismund et al., 2005). In our model to estimate the value of Hill
coefficient we assume 10% ubiquitin binding response for low EGF and 90% for
high EGF. On substituting the concentration values in the equation 2.18
nH =
log(81)
log(20)− log(1.5)
= 1.7 ∼= 2 (2.20)
Hence, in our model we set the Hill coefficient equal to 2.
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2.2 Parameter estimation
Parameter estimation is a process of finding the values of the unknown parameters
of governing model equations such that the model results match with given exper-
imental measurements with minimum error. Being an inverse problem, parameter
estimation does not provide a general solution (Aster et al., 2005). Yet, estimation
of model parameter values is a crucial step in the model development as model
parameters govern the dynamics of the system. Validity of model predictions is
strongly connected to the correctness of parameter values. Our model consists of
a set of ordinary differential equations related by parameters that are unknown and
need to be either measured or estimated. For the optimization algorithm, we imple-
ment the standard approach of minimizing a cost function. The function quantifies
the value of the difference between the model predicted values and the experimen-
tal observed values. Given a model and a set of experimental data, the objective of
model calibration is to find the best realistic guess for unknown parameters. In our
nonlinear optimization algorithm, only those parameter sets are considered valid
solutions that satisfy the experimentally observed biological conditions imposed as
constraints, denoted by (Γ(P )). The best-fit parameters is computed by solving the
following nonlinear optimization problem
Min
m∑
i=1
n∑
j=1
o∑
k=1
(yij(k)− y
p
ij(k))
2 (2.21)
subject to Γ(P )
where, yij(k) is experimental observation and ypij(k) is the model predicted value at
kth time point. The index i run over the experimental condition and j over species
for which measurements are available. P is set of parameters. In this work, we have
two experimental conditions low EGF and high EGF. For parameter estimation we
are using only the control set of data for high EGF (combined data for 100 ng/ml
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and 20 ng/ml of EGF) hence i = 1.
We propose that in the experiments of Sigismund et al. the sorting of the
receptors is more based on ubiquitination status of the receptor than the endocytosis
route used. We consider that in the experimental study receptors population inter-
nalized through the CIE route is ubiquitin-bound and receptor population that used
CME route is ubiquitin-free. Thus, the experimental data regarding the CIE will
correspond to the combined intracellular population of ubiquitin-bound complexes
(Cin and Cen) and dissociation products of these complexes (Ren, Rdu and Len).
Similarly, for the CME measurements correlate to collective intracellular popula-
tion of ubiquitin-free complexes (Cic and Cec) and receptors (Rec) and ligands (Lec)
dissociated from these complexes. The analogies allow us to assign experimentally
measured values to the corresponding model variables. With this information, we
fit the model against the experimental data to obtain the rate constants such as recy-
cling and degradation rates for the ubiquitin-bound and ubiquitin-free complexes,
receptors, and associated ligands.
From the internalization assays, Sigismund et al. calculated the percentage
of EGFR that internalized through CME and CIE. Authors also calculated the per-
centage of CME/CIE internalized EGF that undergoes degradation and recycling.
Using this information a set of conditions have been prepared and converted to
point wise constrains, shown in the table 2.2. Model equations are solved in ac-
cordance with the experimental protocol. To calculate the total and surface EGFR,
equations are solved with initial concentration of EGF (Lm) set to 100 ng/ml and
surface EGFR number (Rs) to 4.5×105/cell. The initial value for all other variables
is set to zero. For the EGF degradation and recycling model equations are simu-
lated for t = 6 min and t = 15 min, respectively, with initial EGF concentration set
to 20 ng/ml. After the this pulse phase, model variable are reinitialized for chase
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CM internalized
(ubiquitin-free)
CI internalized
(ubiquitin-bound)
EGF internalized (after 6 min
of stimulation)
≥ 60 ≤ 40
EGF Degradation (at the end
of chase phase)
≤ 30 ≥ 80
EGF recycled (at the end of
chase phase)
- ≤ 20
Table 2.2: Constrains Γ(P ) placed during the model calibration.
phase with EGF concentration and surface ligand bound receptor population set to
zero. The amount of internalized EGF is measured by summing up all intracel-
lular ligand. From the total internalized EGF, percentages CME internalized and
CIE internalized EGF is calculated. Similarly, amount of EGF internalized during
pulse phase is used to calculate the percentage EGF recycling and degradation. In
addition, to speed up the parameter search we place constrains, such as percent-
age of ubiquitin-free EGF recycled should be higher than the ubiquitin-bound EGF
vise-versa for the EGF degradation. We place a heavy penalty on the individual
parameter set that fails to maintain all the constraints.
Our system contains 13 unknown parameters. To obtain values of these pa-
rameters, we use training data comprising of 18 measurements of 4 species (Surface
EGFR, Total EGFR, EGF degraded, and EGF recycled) with 3 replicates for control
conditions. We used the mean values of 3 replicates to find best set of parameters.
To avoid weighting problem and considering the nature of least square function
which is very sensitive to outliers, during optimization we omit data point at time
point 60 for EGF degradation. Local optimization algorithms like gradient-based
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methods perform well when implemented to find a local minimum. In our case,
degree of freedom and landscape of the objective function preclude use of local op-
timization algorithms. Hence, we opted for a global optimization method namely
genetic algorithm (GA) (Appendix A provides a brief overview of the genetic algo-
rithm). It is more probable that the optimal solution found using GA will lie in the
proximity of a global minimum. We provide a parameter search space by setting
largest possible interval around all the parameters. The interval is decided based
on the values of the similar parameters used in the existing models (French et al.,
1994). Depending on the performance of optimization algorithm in searching the
minimum, the intervals are retuned to get the best possible value for parameter sets.
Each optimization cycle runs up to 500 generations with population size of 100 and
for every generation new population is produced using adaptive mutation function
(MATLAB code is provided in the Appendix A).
2.3 Sensitivity analysis
Parametric sensitivity analysis provides information about the influence of change
in the parameter value on the output of the system. Being a local property, sensi-
tivity can be used to study the change dynamics of a system with variations in the
parameter values. Hence, we use the sensitivity analysis to explore the difference
in the dynamics of EGFR trafficking across different fits. We use the normalized
sensitivity coefficient defined as follows:
sij(t) =
∂ ln(yi(t))
∂ ln(pj)
(2.22)
where, sij(t) is the sensitivity of ith observable variable yi (such as total EGFR
percentage) with respect to change in the change in the jth parameter in pj . We
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convert this sensitivity index into a time independent values by integrating it over
observation time.
Sij =
1
T
∫ T
0
|sij(t)|dt (2.23)
where, T is the final time point of observation and we use absolute values of sensi-
tivity to avoid negative and positive cancellation.
We use software package OpenBio for sensitivity analysis using a code writ-
ten in Jacobian, a scripting environment in OpenBio, to calculate average sensitiv-
ity. To quantify the variability in EGFR dynamics between different fits we calcu-
late the correlation coefficient (R) for parameter sensitivities among the fits.
2.4 Identifiability analysis
Identifiability analysis deals with the problem of uniqueness of the parameter set ob-
tained from model calibration exercise (Cobelli and DiStefano, 1980; Bellman and
A˚stro¨m, 1970). If a model is not uniquely identifiable, several or infinite parameter
sets can generate identical results for model fitting. Hence, parameter identifiability
analysis plays a critical role in deciding the accuracy of the model predictions. In
general, structural or practical unidentifiability precludes the optimization process
from providing a unique solution. Structural (priori) identifiability as name suggests
depends on the structure of the model, available measured output and it provides an
estimate of information that can be obtained from the experiments. On the other
hand practical identifiability depends not only on model structure but also on ex-
perimental conditions in combination with quantity and quality of the measured
data (Bellman and A˚stro¨m, 1970). Structural unidentifiability can be resolved ei-
ther by reducing redundant parameters of the model or by increasing the numbers
of measured model variables.
2 Identifiability analysis 21
We performed identifiability analysis using the software toolbox SensSB de-
veloped for MATLAB (Rodriguez-Fernandez and Banga, 2010). We use the tool-
box to calculate the correlation matrix that provides the information about inter-
dependence between the model parameters (details in the Appendix B). The ex-
periments cannot always provide data for all the involved species. In most cases,
indirect measurements such as concentration of related species or cumulative mea-
surements for a group species are practically possible. Thus, very often it is difficult
to distinguished between structural and practical identifiability with the available
experimental data. The problem of limited data can be addressed by providing
measurements for each variable (specie) of the model. The SensSB toolbox allows
us to generate simulated data for each model variable (specie). The data are then
used to determine the structural identifiability of the model. In many cases, even
if a model is structurally identifiable, parameter optimization may fail to determine
definitive parameter values due to practical unidentifiability. Information gathered
through SensSB toolbox will be helpful in finding out whether the limitations in
parameter estimation are emerging from the data or from model structure.
Chapter 3
Model results
Our primary goal is to study the regulatory influence of ubiquitination on the en-
docytosis and transport of EGFR. In order to achieve a realistic estimate of the
parameters, we fit our model against the control measurements from (Sigismund
et al., 2008), where normal HeLa cells are exposed to high EGF dose.
3.1 Parameter estimates
Using the genetic algorithm we obtain different parameter sets that fit the experi-
mental data equally well. Coefficient of variation for parameter value shows some
parameters such as kec, ku and kln to remain approximately constant across multi-
ple fits, we term them well constrained. While some parameters such as krn, kdrc
and kdrn to vary, termed poorly constrained. The observations are visible in the
box plot (Figure 3.1(a), 3.1(b)) . The characteristics of some parameters being well
constrained while some being poorly constrained, define a “sloppy” model (Brown
and Sethna, 2003) and it is almost a universal property of nonlinear multi-parameter
system biology models (Gutenkunst et al., 2007). The observed sloppiness hinders
22
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Figure 3.1: Box plot showing parameter values and their variation.
genetic algorithm from finding the exact global minimum of cost function. The
existence of different sets of parameters for which the model behavior is consistent
with the data, indicates a wide flat valley in objective function domain. To check for
the possibility that our algorithm is getting stuck-up in the flat valley of objective
function, areas outside of valley have been explored by initiating the algorithm in
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different parts of objective function. The results confirm that the best fit parameters
are inside of flat valley. In a collective fit, the parameter set ensemble samples from
all consistent sets of parameters. Sloppy models are very insensitive to parameter
combinations that lie along sloppy directions. The parameter sets ensemble can
extend very far in those directions. Since, discrepancy between different fits with
residue value less than experimental error is practically not significant (Chen et al.,
2009), we consider all fits with a root mean square deviation (RMSD) of approxi-
mately 10% or less from real measurement to be equally good. We collect 21 such
parameter sets for further analysis and parameter set with lowest RMSD is consid-
ered as best-fit and table 3.1 shows the best-fit parameter values.
3.2 Model fitting
Results of the model simulations with 21 parameter sets are shown in the figures
3.2 and 3.3. Figure 3.2(a) shows simulation results and experimental data of to-
tal EGFR. In the experiments, cells were exposed to high EGF does (100 ng/ml)
and total EGFR level was monitored using the Immunoblotting. The measurements
shows drop in the total EGFR count with time post stimulation. The observed drop
is due to the slow and steady degradation of receptors in the lysosomes. The loss of
receptors with time slowly ceases trafficking and subsequently terminates the sig-
naling. For the surface EGFR, cells were exposed to high EGF does (100 ng/ml)
and surface receptor count was measured using 125I-EGF. The data show that recep-
tors internalize after the EGF binding causing ligand-bound receptors to disappear
from the cell membrane. The down-regulation of EGFR lowers the surface count
and also reduces the signaling originating from cell membrane. Figure 3.2(b) shows
the effect of EGF stimulation on the surface EGFR.
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Variable Best fit values
kb 0.063 nM−1 min−1 ∗
kub 0.16 min−1 ∗
ku 0.069546 min−1
kec 0.076521 min−1
ken 1 min−1
kee 0.076204 min−1
keb 0.0085 nM−1 min−1 ∗
keub 0.66 min−1 ∗
krc 0.19147 min−1
krn 0.11565 min−1
klc 0.026875 min−1
kln 0.0030627 min−1
kdrc 0.041646 min−1
kdrn 0.16102 min−1
kdlc 0.015714 min−1
kdln 0.030311 min−1
kdu 0.14123 min−1
Table 3.1: List of parameter with their best-fit values used for the model simula-
tions. ∗ value taken from literature (French et al., 1995).
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Figure 3.2: Model simulation results for 21 equally good fits showing change in
EGFR count with time post high EGF stimulation (Dark line represents best-fit
results). Symbols represent experimental data (Sigismund et al., 2008).
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Figure 3.3: Model simulation results for 21 best fits showing EGF recycling and
degradation with time post high EGF stimuli. Symbols represent experimental data
(Sigismund et al., 2008).
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To estimate recycled and degraded EGF pulse-chase experiments were car-
ried out. For the degradation measurements in the pulse phase HeLa cells were
exposed to high 125I-EGF (20 ng/ml) for 6 minute and during the chase phase cell
were kept in the medium with or without excess EGF (∼ 200 ng/ml) (Sigismund
et al., 2008) data were collected for percentage of internalized 125I-EGF that de-
graded with time. For the recycling, pulse phase was of 15 minute and during
the chase phase data were collected for percentage of internalized 125I-EGF that
was present in the medium. Ligand degradation profile shows an increase in the
percentage of degraded EGF (Figure 3.3(b)) with time and similarly there is an in-
crease in the percentage of recycled EGF in the medium (Figure 3.3(a)).
3.3 Variation in parametric sensitivity
The sensitivity analysis of the model revels important information about the behav-
ior of the system. The sensitivity coefficients for four species have been computed
for the 21 equally good fits. The results of sensitivity analysis have been shown in
figure 3.4 and 3.5. We observe variation in the sensitivity values across different
fits. For some parameter the variation in the sensitivity is high and some parame-
ters have no major contribution to the sensitivity. These variations may arise due to
the change in the dynamics of the system. To investigate and measure the change
in the dynamics we compared the sensitivity values from one fit with another.
Comparison between the results of different acceptable fits can be used as a ruler
to measure change in dynamic behavior of system due to poorly constrained pa-
rameters. The results of correlation between parametric sensitivity coefficients in
different fit are shown for 5 representative fits in figure 3.6 and 3.7. The average
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Figure 3.4: Box plot showing sensitivity variation for total and surface EGFR.
correlation, R ≈ 0.98 confirms consistent and almost unique behavior of the sys-
tem.
Although, because of sloppiness, the optimization method is not able to find
the global minimum of cost function but result of sensitivity analysis for collective
fits confirm that our model shows a constant dynamic behavior for all 21 parameter
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(b) Sensitivity box plot for EGF degradation
Figure 3.5: Box plot showing sensitivity variation for recycled and degraded EGF.
sets. Thus, we consider that a flat valley of the global minimum lies in the parameter
search space.
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Figure 3.6: Correlation between sensitivity values of 5 representative best fits.
Above diagonal plots show correlation of surface EGFR between fits and below
diagonal plots show correlation of total EGFR between fits. Values in the plot rep-
resents correlation coefficient (R) between each two fits.
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Figure 3.7: Correlation between sensitivity values of 5 representative best fits used
in Figure 3.6. Correlation plots for EGF degraded (above diagonal) and EGF re-
cycled (below diagonal). Values in the plot represents correlation coefficient (R)
between each two fits.
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3.4 Mean values for parameters
Simulations for the 21 fits and the sensitivity correlations indicate presence of a flat
valley in the objective function. This hinders the optimization process from finding
the exact solution. Considering that the 21 fits is a small sample size to accurately
compute mean and standard deviation, we decided to run the optimization algo-
rithm (GA) for large number of time in order to collect big enough sample size that
will allow us to compute mean and confidence intervals. With this information we
can conclusively propose the most identifiable and least identifiable parameters. In
order to achieve this we performed the GA for about 4000 times and with ≈ 25%
success rate we gathered 1022 parameter sets with final RMSD score of less than
10%. The distribution over the obtained parameters remains unknown. Hence, we
calculate the confidence interval on the mean parameter values (Table 3.2) using
Chebyshev’s inequality, which states that at least 100(1 − 1
k2
)% of data lie around
the mean µ in the interval ±kσ where σ is standard deviation. Table shows the
parameter mean value and 95% confidence interval (values of k is 4.47). Here after
we use the mean parameter values for the further model simulations and analysis.
Using the mean parameter values we simulated the model to study the wellness of
fit. We observe that with the mean values model is able to capture the data well.
Figure 3.8 and 3.9 show the model simulation results with mean parameter values.
3.5 Sensitivity analysis with mean values
Using the mean parameter values, we conducted sensitivity analysis to observe the
contribution of each parameter to the dynamics of the system. We also study the
relation between the sensitivity of the parameter and its identifiability, which is re-
lated to confidence interval. Large confidence interval and low sensitivity of the
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Variable Mean µ Std. Deviation σ Confidence interval ±k × σ
ku 0.0729 min−1 0.0069 0.0308
kec 0.0795 min−1 0.0061 0.0271
ken 0.9463 min−1 0.1054 0.4713
kee 0.0789 min−1 0.0132 0.0589
krc 0.2256 min−1 0.0713 0.3186
krn 0.3038 min−1 0.1585 0.7087
klc 0.0307 min−1 0.0073 0.0328
kln 0.0028 min−1 0.0009 0.0042
kdrc 0.0301 min−1 0.0183 0.0819
kdrn 0.5133 min−1 0.2114 0.9448
kdlc 0.0184 min−1 0.0044 0.0197
kdln 0.0332 min−1 0.0022 0.0098
kdu 0.1513 min−1 0.0279 0.1245
Table 3.2: List of fitted parameters with mean values and confidence interval.
parameter may lead to unidentifiability. In our model we observe that many param-
eters have huge confidence intervals and low over all sensitivity (Figure 3.10 and
Table 3.2).
Sensitivity analysis demonstrates the importance of the parameters in dif-
ferent phases of the dynamics and with respect to species. We find ubiquitination
rate (ku) to be the most sensitive parameter in the system. This finding clearly re-
flects the importance of receptor-ubiquitin binding in the regulation trafficking. The
parameter ken shows low sensitive in all the stages of dynamics thus we speculate
that GA is unable to estimate the value for ken (CIE rate) and reaches boundaries of
the defined optimization range, even extending the upper bound on the parameter
did not provide a unique solution. Thus, we consider the parameter to be unidenti-
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Figure 3.8: Model simulation results for mean parameter values showing change in
EGFR count with time post high EGF stimulation. Symbols represent experimental
data (Sigismund et al., 2008).
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Figure 3.9: Model simulation results for mean parameter values showing EGF re-
cycling and degradation with time post high EGF stimuli. Symbols represent ex-
perimental data (Sigismund et al., 2008).
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Figure 3.10: Results of sensitivity analysis with mean parameter values.
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fiable and define the parameter search space in the range 0.5 to 1. System clearly
shows high sensitivity to other trafficking events controlled by kec and kee during
the initial phase of the dynamics. During the continuous EGF stimuli the param-
eters controlling the processes at cell surface are more sensitive. The parameters
dictating the fate of ligand are insensitive to the total and surface EGFR dynamics.
During the chase phase analysis revels the importance of each parameter in EGF
recycling and degradation, kdlc and kdln appears to be very sensitive with respect
to degradation and klc with EGF recycling. Parameters controlling the intracellular
receptor dynamics show less influence on the EGF recycling and degradation. Due
to the absence of EGF stimuli in the chase phase surface parameter do not show any
influence on the down stream dynamics. The parameter variability and their sensi-
tivities clearly indicate that not all model parameter can be identified. For most of
the systems biology models unidentifiability arises due to the use cumulative mea-
surements for calibration. We argue that the in our study, unidentifiability is more
due to the limited data and less due to the structure of the model. In the next section
we aim to investigate cause behind the unidentifiability of the model parameters.
3.6 Model identifiability
To further investigated whether the unidentifiability is arising from the model struc-
ture or form practical limitations of experimental measurements. We used a MAT-
LAB toolbox ‘SensSB’ which provides a platform to investigate the structural iden-
tifiability. For this purpose the toolbox generate simulated data for all the model
variables with zero noise. The simulated data represent an ideal experimental setup
where measurements are available for all the species of the system (Figure 3.11).
With the simulated data, we can speculate that all the non correlated rate constants
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Figure 3.11: Simulated data generated for all the model variables using SensSB.
Mean parameter values were used to generate the data.
in the model can be estimated. If there exist a high correlation between parame-
ters then their estimation will be hindered due to the interdependence (Rodriguez-
Fernandez et al., 2006; Miao et al., 2011). The correlation matrix calculated using
the toolbox gives information about the interrelationships between the parameters
and thereby about the structural identifiability. In the matrix a correlation index
value 0.95 or higher signifies high degree of correlation between the two parame-
ters (see Appendix B). For our model, we investigated this interdependence in order
to identify the correlated model parameters that are not identifiable due to the struc-
ture of the model. Figure 3.12 shows color plot of the parameter correlation matrix
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with each squares representing the correlation value between the two parameters.
Correlation matrix calculated by SensSB toolbox shows that no pair of parameters
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Figure 3.12: Parameter correlation matrix represented as color plot depicting cor-
relations between the parameters.
is highly correlated (no parameter pair with correlation higher than 0.95). These
results suggest the model parameters to be identifiable provided that the sufficient
data are available. During the analysis we provided data for all the model variables,
which is an ideal situation. Under these conditions we find no high interdepen-
dence between parameters hence we speculate that model is structurally identifi-
able. However, the correlation matrix also provides information about the negative
and positive correlations between the parameters yet lower than the threshold of
0.95. These low correlations provide information about the interrelationships be-
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tween the parameters.
The calculations done so far are based on the local sensitivity analysis car-
ried out in the close range of mean parameter values. Hence, the matrix obtained
is also termed as local correlation matrix obtained for local identifiability analysis.
A pseudo-global identifiability analysis can be performed using SensSB to inves-
tigate the interrelationship between the parameter over a wider range of parameter
values. Figure 3.13 shows a color plot of the pseudo-global correlation matrix. The
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Figure 3.13: Pseudo-global correlation matrix represented as color plot depicting
correlations between the parameters.
results of the pseudo-global identifiability analysis reveals that there are no pairs
of parameters too highly correlated (no correlations greater than 0.95). The re-
sults of local and pseudo-global analysis confirm low interdependence between the
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parameters and indicate that model parameters can be identifiable. The findings of
identifiability analysis further strengthen our argument that the model is structurally
identifiable. Therefore, we propose that the parameter estimation is more limited
by the measured data rather than structure of the model.
As mentioned previously the parameter unidentifiability in systems biology
models also known as sloppiness is universal and mostly arise due to the techno-
logical limitation in the data acquisition (Gutenkunst et al., 2007). Considering the
limitations in obtaining unique values of the model parameters, it is argued that
validation and utility of model should be judged based on the accuracy with which
the model can make predictions (Wang et al., 2009; Chen et al., 2009; Brown and
Sethna, 2003; Gutenkunst et al., 2007). In the next chapter (Model predictions) we
test our model for its capabilities in providing qualitatively as well as quantitatively
accurate predictions.
Chapter 4
Model predictions
4.1 Effect of endocytosis inhibitors
In the model we consider CME and CIE as two independent routes of internal-
ization and rate receptor flow through these routes is governed by the values of
rate constants kec and ken, respectively. Thus, structure of our model permits us to
distinguish between two subpopulations of internalized EGFR: CME internalized
(ubiquitin-free) and CIE internalized (ubiquitin-bound). It is an advantage over the
existing models, which allows us to control each endocytic route and monitor each
subpopulation. Model also allows us to specify for each subpopulation a different
set of values for rate constants such as internalization rate, recycling and degrada-
tion rates for both ligand and receptor. These features of the model let us illustrate
the change in EGFR trafficking pattern for obstructed endocytosis route. In order to
switch off CME or CIE route in the model, we set the corresponding internalization
rate to zero. Simulation results for the closed CME and closed CIE show an altered
EGFR localization (Figures: 4.1, 4.2, 4.3, and 4.4).
With CME mode turned off, ligand-receptor complexes undergo ubiquitina-
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tion activating the CI internalization. As all the internalizing complexes are tagged
with ubiquitin, inside the endosome these complexes are targeted to the lysosome
at a higher rate compared to their recycling. For the surface EGFR, model results
show a slightly delayed drop in the level of EGFR due to a delayed internalization
arising from the intermediate ubiquitination reaction (Figure 4.1(b)). In control
state, post ligand binding ubiquitin-free receptors can as well internalize through
the CME. However, the initial lag in receptor internalization has no significant in-
fluence on the later phase of the dynamics. Towards the end, the surface EGFR level
for CME inhibition decreases to zero due to the targeting of receptors for lysosomal
degradation. In line with the argument that ubiquitin binding efficiently targets the
receptors for lysosomal degradation, model results show a steep drop in total EGFR
(Figure 4.1(a)).
On the contrary, when CI internalization rate is set to zero, only the ubiquitin-
free complexes manage to internalize through CME route and ubiquitin-bound com-
plexes appear to remain at the cell surface. Model simulations show an initial drop
in the surface EGFR level due to the clathrin mediated (CM) internalization of
ubiquitin-free complexes. The high recycling of these complexes and their dissoci-
ated receptors is responsible for the observed reappearance of surface EGFR (Figure
4.2(b)). The total EGFR count drops at a much slower rate than the control because
of high recycling and low degradation (Figure 4.2(a)). We compare these model
predictions against experimental data. In the experiments, CME route is blocked by
clathrin knockdown (clathrin-KD) while a cholesterol-binding drug Filipin is used
to hinder the CIE route. We find qualitative agreement between the experimental
data and our model predictions. This suggests our model can accurately capture the
altered surface and total EGFR localization in presence of endocytosis inhibitors.
Several experimental studies show that the sorting of EGFR in the endo-
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Figure 4.1: Model simulation results for mean parameter values showing change in
EGFR count with time, post high EGF stimulation. Continuous line shows simu-
lation results for control condition and ( ) represents simulation with kec set to
zero.
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Figure 4.2: Model simulation results for mean parameter values showing change in
EGFR count with time, post high EGF stimulation. Continuous line shows simu-
lation results for control condition and ( ) represents simulation with ken set to
zero.
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some depends on the ubiquitination status of the receptor (Haglund et al., 2003;
Weissman, 2001). Hence, we assume that ubiquitin dependent sorting mechanism
is present in the experiments of Sigismund et al. and that ubiquitin binding is re-
sponsible for targeting the ligand and receptors for lysosomal degradation. Hence,
to obtain the proposed sorting, we placed constrains in the optimization algorithm
(Table 2.2). This allows the algorithm to search for parameters that not only provide
the proposed sorting but also to capture the control measurement data. Remarkably,
our model results with endocytosis blocking are in agreement with the inhibition ex-
periments. When the CME route is turned-off, model results show high degradation
and low recycling of the internalized EGF in accordance with the proposed sorting
(Figure 4.3(b) and 4.3(a)). Upon comparing the model results with clathrin-KD
experiments, we find an overestimation of recycling and underestimation of degra-
dation. For the case of CIE inhibition, model results for EGF recycling and degra-
dation appear to show a near quantitative match with Filipin data (Figure 4.4(a) and
4.4(b)). These results show that with the assumption of ubiquitin based sorting, our
model can qualitatively explain the change in EGFR localization induced due to the
selective inhibition of endocytosis.
Quantitative comparison with inhibition data: Use of clathrin-KD or Filipin
fails to provide a complete inhibition of the respective endocytosis. We speculate
that the CM internalization with clathrin-KD must be lower than the control. Con-
sidering this aspect of the knockdown, we fit the model against the clathrin-KD
data with CME rate to be the only free parameter and keep values of rest of the
parameter unchanged (Figure 4.5 and 4.6). We use a gradient-based non-linear fit-
ting algorithm, available in MATLAB (lsqcurvefit) to estimate the CME rate. As
speculated, the best-fit estimate for CME rate is considerably lower than the con-
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Figure 4.3: Model simulation results for mean parameter values showing EGF re-
cycling and degradation with time, post high EGF stimuli. Continuous line shows
simulation results for control condition and ( ) represents simulation with kec set
to zero.
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Figure 4.4: Model simulation results for mean parameter values showing EGF re-
cycling and degradation with time, post high EGF stimuli. Continuous line shows
simulation results for control condition and ( ) represents simulation with ken set
to zero.
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Figure 4.5: Model simulation results showing effect of clathrin KD ( ) and Filipin
( ) on the change in EGFR count with time, post high EGF stimulation. Symbols
represent data for clathrin-KD (!) and Filipin (") (Sigismund et al., 2008).
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Figure 4.6: Model simulation results showing effect of clathrin KD ( ) and Filipin
( ) on EGF recycling and degradation with time, post high EGF stimuli. Symbols
represent data for clathrin-KD (!) and Filipin (") (Sigismund et al., 2008).
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trol value. With the use of estimated CME rate, our model captures dynamics of
surface EGFR, degradation and recycling of EGF (Figure 4.5(b), 4.6(b) and 4.6(a)).
Compared to the clathrin-KD data, our model over-estimates the loss in total EGFR
(Figure 4.5(a)). The reason behind this increase in half-life of total EGFR remains
unclear.
Furthermore, Sigismund et al. use a cholesterol-blocking drug called Filipin
in order to obstruct the CI internalization. As it has been argued that the change
in cholesterol level can influence the EGFR activity (Ringerike et al., 2002), we
suspect that the presence of Filipin may have an influence on the ubiquitination
process. Considering this effect, we set ubiquitination rate and CIE rate as free
parameters while fitting the model against the Filipin data and keep the values of
other parameters unchanged. We use the same fitting algorithm from MATLAB as
above. Results of this fitting provide estimates for both the free parameters that are
lower than the control, with the value of CIE rate value being equal to zero. With
two refitted parameters, our model successfully captures the data (Figure 4.5 and
4.6).
The model results obtained with and without fitting show that for high EGF
dose our model can accurately capture the dynamics of EGFR trafficking. Further,
our model is able to reproduce the effect of endocytosis inhibition on surface EGFR,
total EGFR and on EGF degradation and recycling. These results further support
the assumption that ubiquitination is responsible for surface as well as endosomal
sorting of the receptors.
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4.2 EGFR transport at low EGF dose
Thus far, we use the model to study the EGFR dynamics in high EGF condition.
Due to the use of Hill kinetics, the extent of receptor ubiquitination follows a sig-
moidal behavior as a function of EGF concentration. This causes negligible receptor
ubiquitination for low EGF level whereas at high EGF level, significant amount of
receptors undergo ubiquitination. The negligible amount of ubiquitin binding gen-
erates insignificant amount of CI internalization. Hence, at low EGF stimuli, most
of the ligand-receptor complexes are ubiquitin-free and internalization is predomi-
nately through CME route. Here we use our model to study change in the dynamics
of EGFR transport with respect to EGF stimuli. We simulate the model with ex-
tracellular ligand concentration (Lm) set to a physiologically low value (1.5 ng/ml)
(Sigismund et al., 2008, 2005) and use the parameter values obtained throughmodel
calibration with high EGF control measurements.
Simulation results when compared to high EGF, show considerably slower
drop in the surface EGFR level (Figure 4.7(b)). The total EGFR population drops at
a slow pace, showing a prolonged EGFR trafficking (Figure 4.7(a)). Inside the en-
dosome, majority of the internalized complexes, dissociated receptors and ligands
are ubiquitin-free. According to proposed ubiquitin dependent endosomal sorting,
these complexes, receptors and ligands are more liable for recycling than for degra-
dation. Results for EGF recycling and degradation show a similar trend. Contrary to
the high EGF stimuli, model simulations for low stimuli show a decrease in degra-
dation and an increase in recycling of EGF (Figure 4.8(b) and 4.8(a)). Remarkably,
results of the model simulation are in quantitative agreement with the low EGF data
(Sigismund et al., 2008) (Figure 4.8(b)). These results show that our model can
explain the dynamics of EGFR for low EGF stimuli. It also implies that at low EGF
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Figure 4.7: Model simulation results show change in EGFR count with time, for
low EGF stimuli ( ) and high EGF stimulation continuous line.
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Figure 4.8: Model simulation results show change in EGFR count with time, for low
EGF stimuli ( ) and high EGF stimulation continuous line. Symbols represent
data for low EGF (!) (Sigismund et al., 2008).
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dose, ubiquitin binding is negligible and supports the assumption of sigmoidal be-
havior of ubiquitin binding as a function of EGF dose. From these results, it can be
interpreted that very low receptor ubiquitination leads to low degradation and high
recycling which keeps the receptor in circulation for longer time. This prolonged
EGFR trafficking causes a sustained signaling (e.g. AKT and ERK signaling) as
seen in findings of Sigismund et al. (2008).
4.3 Dynamics of ubiquitination defective EGFR
Mutations in EGFR are known to cause dysfunctional EGFR trafficking leading to
cancer and other cell cycle related defects (Gschwind et al., 2004). Defective ubiq-
uitination in EGFR is considered responsible for prolonged EGFR signaling and
is associated with cancer (Gschwind et al., 2004; Peschard and Park, 2003). Us-
ing our model, we aim to understand the effect of defective ubiquitination on the
dynamics of EGFR transport. We also validate the model predictions against the
experimental data of Y1045F EGFR mutant (supplementary text from Sigismund
et al. (2008)). In these experiments, total EGFR and EGF recycling are measured
for both wild type EGFR (wt-EGFR) and Y1045F mutant EGFR (mutant-EGFR).
In order to avoid the interference from endogenous EGFR, the mutant-EGFR is
expressed in NR6 fibroblasts lacking endogenous EGFR and for control measure-
ments wt-EGFR is expressed.
To simulate ubiquitin defective mutant-EGFR, we set the ubiquitination
rate to zero. Interestingly, our model qualitatively predicts the experimentally ob-
served trafficking of both wt-EGFR andmutant-EGFR (Figure 4.9 and 4.10). Model
predictions show that with no receptor ubiquitination, CIE route remains inactive
forcing all the ligand-receptor complexes to internalize through CME route. Inside
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Figure 4.9: Model simulation results show change in EGFR count with time, for
mutant EGFR ( ) and wt-EGFR continuous line. Symbols represent data for
mutant (◦) and wild-type (•) EGFR (Sigismund et al., 2008).
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Figure 4.10: Model simulation results show change in EGFR count with time, for
mutant EGFR ( ) and wt-EGFR continuous line. Symbols represent data for
mutant (◦) and wild-type (•) EGFR and error bars represent 8% of mean (Sigismund
et al., 2008).
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the endosome, these ubiquitin-free complexes are sorted for recycling with higher
probability than for degradation. Model predictions for the mutant EGFR show that
after the initial decline, the surface EGFR level remains at higher level compared to
the wt-EGFR (Figure 4.9(b)). Low degradation keeps mutant-EGFRs in circulation
for longer time, causing an increase in half-life of the receptors. Our model pre-
dictions show a qualitative match with data of total mutant-EGFR (Figure 4.9(a))
and near quantitative match with recycled EGF data (Figure 4.10(a)). The drop in
EGF degradation is also visible in model predictions (Figure 4.10(b)). Experiments
with Y1045F mutant show no significant difference in the behavior of total EGFR
and EGF recycling in the presence or absence of Filipin. The unaltered dynamics
of mutant-EGFR in the presence of Filipin suggests a link between ubiquitination
and the activation of CIE. With the ubiquitination rate set to zero in our model,
any change in the CIE rate will not have an influence on the trafficking of mutant-
EGFR. These results support the model assumption that receptor-ubiquitin binding
is a prerequisite for active CI internalization.
Comparison between simulation results of wt-EGFR andmutant-EGFR clearly
reflect the key function of receptor ubiquitination in down-regulating EGFR signal-
ing. Model simulations show that ubiquitin binding initiates CI internalization and
targets the ubiquitinated receptors for lysosomal degradation. Defect in ubiquitin
binding leads to prolonged trafficking of mutant-EGFR due to low degradation and
high recycling. Experimental data show an over-activation of AKT and ERK for
Y1045F mutant (Sigismund et al., 2008). The model predictions can explain these
results as high recycling, low degradation, and increased recirculation of signaling
EGFRs could cause an over-stimulation of AKT and ERK pathway.
Chapter 5
Conclusions and discussion
Readjustments in the speed of EGFR recycling and degradation depending on the
amplitude of stimuli can control overstimulation in signaling. In case of EGF in-
duced signaling, shift from CME to CIE route changes the EGFR localization and
modifies the signaling. In this work, we provide a mathematical model of EGFR
trafficking with receptor ubiquitination as a key regulatory mechanism that alters
the EGFR transport. Experimental studies using ubiquitin defective EGFR mu-
tant show that receptor ubiquitination is not necessary for the receptor endocytosis
(Jiang and Sorkin, 2003; Waterman et al., 2002). In addition, it is being proposed
that receptor ubiquitination activates clathrin-independent route of endocytosis and
ubiquitin binding is observed to be a prerequisite for the CI internalization of EGFR
(Sigismund et al., 2005). These observations are in favor of the assumption that
ubiquitin-free complexes internalize through CME and receptor ubiquitination at
the cell membrane initiates the CI internalization.
The structure of our model allows us to study the effect of ubiquitination on
the EGFR degradation and recycling. Unlike existing models of EGFR trafficking,
our model specifically includes dose dependent receptor ubiquitination that func-
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tions as a regulatory step and incorporates two modes of endocytosis. We calibrated
the model using the experimental data from Sigismund et al. (2008). High corre-
lation between sensitivities of different fits shows that the dynamics of the system
remains unchanged among obtained fits (Figure 3.6 and 3.7). Considering the high
correlations, we speculate that the obtained fits are in the neighborhood of a global
optimal. In order to get an accurate estimate for the parameters, a large number of
parameter sets are obtained by running the GA code multiple times. Using these
fits we calculated mean and confidence interval over the parameters. We observe
that the simulations carried out using mean parameter values can reproduce the ex-
perimental data (Figure 3.8 and 3.9). Thus, we reason that using mean parameter
values our model can make accurate predictions.
The experimental observations suggest a switch-like behavior in ubiquitin
binding in response to the rising extracellular EGF concentration (Sigismund et al.,
2005). Different review articles also argue for a similar idea of concentration de-
pendent ubiquitination initiating EGFR sorting (Acconcia et al., 2009; Woelk et al.,
2007). This points to a regulatory mechanism responsible for the surface sorting of
ligand-receptor complexes depending on the EGF concentration. Use of Hill kinet-
ics in our model gives rise to a sigmoidal behavior in ubiquitin binding rate. Due to
which model predicts an insignificant ubiquitin binding at low EGF dose. At high
EGF dose, a sharp increase in ubiquitination divides receptors into ubiquitin-free
subpopulation internalizing through CME and ubiquitin-bound subpopulation that
uses CIE. Speedy degradation of the ubiquitin-bound receptors then causes rapid
down-regulation in EGFR trafficking and associated signaling.
Another explanation about EGFR surface sorting comes from a computa-
tional study that assumes CME saturation at high EGF stimuli (Schmidt-Glenewinkel
et al., 2008). Authors claim overloading of the CME route forces the receptors
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into the CIE route reasoning that at high EGF concentration, depletion of limiting
factors such as adapter proteins and/or cage proteins during CME causes satura-
tion. However, an experimental study by Warren et al. (1997) shows saturation of
transferrin receptor (TfR) (20 fold increase in TfR count), which exclusively uses
CME, does not have a significant influence on the endocytosis of EGFR. These find-
ings clearly indicate that internalization rate of EGFR remains unaffected, although
there is an excessive consumption of clathrin molecules for CM internalization of
overexpressed TfR. In the study of Sigismund et al. (2008) knockdown of adaptor
protein-2 (AP2) is relatively less effective, in blocking CM internalization as com-
pared to clathrin-KD. This observation signifies that limitation of adaptor protein
has lesser influence on the CME probably due to the presence of alternative adaptor
proteins. At low EGF dose, knockdown of CME components may induce saturation
in CME and activation of CIE route. In contrast, knockdown experiments with low
EGF show no significant utilization of CIE route (Sigismund et al., 2008, 2005).
In addition, we argue that continuous recycling maintains a steady supply of CME
component molecules at the cell membrane. Thus, we propose that CIE route is
activated irrespective of CME saturation.
To study the role of different modes of endocytosis in EGFR trafficking, we
block each of the endocytosis routes alternatively by setting corresponding inter-
nalization rate to zero (Figure 4.1, 4.3 and 4.2, 4.4 ). With the CIE rate set to zero,
model predictions show increased recycling which leads to a prolonged EGFR traf-
ficking and signaling. In contrast, restricting the CM internalization causes surface
EGFR to undergo ubiquitination prior to internalization through CIE route. In-
creased degradation and reduced recycling lead to termination of EGFR transport
and associated signaling. These simulation results show that EGF receptors meet
different fate depending on their choice of internalization route. In a similar fashion,
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transforming growth factorβ (TGF-β) receptors meet different fate and activate dif-
ferent signaling pathways depending upon the mode of endocytosis (Di Guglielmo
et al., 2003). The study also finds degradation of CIE routed receptor to be respon-
sible for negative regulation of TGF-β signaling.
For low EGF concentration, our model predictions show that receptor-ubiquitin
binding reaction occurs at a slow rate, producing insignificant amount of ubiquiti-
nated receptors (Figure 4.7 and 4.8). CI internalization is minimal and CME ap-
pears dominant, keeping receptors in circulation for a longer time allowing a pro-
longed EGFR trafficking. The model predictions, for both high and low EGF dose
endorse the existence of a switch like behavior in ubiquitination and subsequently
support the assumption of EGF stimuli dependent change in the preference of inter-
nalization route. A similar shift in mode of endocytosis depending on the stimulus
concentrations has been reported for platelet-derived growth factor induced recep-
tor trafficking (De Donatis et al., 2008).
Ubiquitination deficient EGFR mutants are connected to various cancers. In
our model, we simulate one such mutant by setting the ubiquitination rate to zero
(Figure 4.9 and 4.10). Predictions show significant difference in the surface and
total EGFR level, with mutant receptors showing a slower drop than wt-EGFR. De-
fective ubiquitination causes minimal lysosomal degradation leading to prolonged
EGFR trafficking. In addition, the model predictions for ligand degradation and re-
cycling agree with experimental data of Jiang and Sorkin (2003). We argue that the
prolongation of EGFR transport is responsible for experimentally observed over-
stimulation in AKT signaling (Sigismund et al., 2008). These simulation results
reflect the importance of receptor ubiquitination in controlling the EGF induced
signaling.
The simulation results illustrate the regulatory function of ubiquitin binding
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in EGFR trafficking and implications of defective ubiquitination. Yet, the mecha-
nism that converts a graded extracellular signal into an all-or-none response of ubiq-
uitin binding is unknown. Based on the nature of ubiquitin binding various theories
have been proposed. One speculation is based on a possible Grb2 mediated cooper-
ative Cbl binding (Acconcia et al., 2009). However, some other mechanisms such
as the E1-E2-E3 enzyme reaction cascade and/or possibility for cooperative bind-
ing during poly-ubiquitination may give rise to ultrasensitivity. Details about the
mechanism of EGFR-ubiquitin binding will help explore functioning of the sens-
ing mechanism that cells use to detect change in the environment. Considering the
limitations, we use Hill kinetics to replicate the proposed switch like response in re-
ceptor ubiquitination. This simplification allows us to develop a usable model, yet
it limits the reach of our understanding about the mechanistic details of ubiquitin
binding and their role in activation of CIE.
Inside the endosomes, sorting of receptors depending on the ubiquitination
status plays a key role in deciding the fate of the signaling receptors. It is well
recognized that ubiquitin bound receptors are more prone to lysosomal targeting.
Details about the functioning of ubiquitin detection system involved in the endo-
somal sorting remain obscure, limiting further advancements in the model. In our
model, difference in the rate constant values for the ubiquitin-bound and ubiquitin-
free receptor populations is responsible for the proposed endosomal classification.
It is of great interest to identify the key components that participate in the detec-
tion of ubiquitin-bound receptor. The answer to this query may lie in the choice
of CIE. Further investigations are needed to gain a deeper understanding about the
CIE activation and its influence on the endosomal configuration. Results of the
model simulations approve of ubiquitin regulated surface and endosomal sorting of
EGFR. Yet, it is too early to generalize the idea of ubiquitin regulated sorting, as
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across different cell types and/or subtypes diverse mechanisms may exist that regu-
late the EGFR signaling. Hence, to avoid misinterpretation it will be appropriate to
limit the scope of the model to experimental conditions under which the measure-
ments are made (Sigismund et al., 2008).
Simulation results clearly indicate that our model captures the experimen-
tally observed effects of endocytosis inhibition reflecting the regulatory role of
ubiquitination in EGFR endocytosis and in the downstream sorting. Model predic-
tions for low EGF dose emphasize the presence of a switch like behavior in receptor
ubiquitin binding. Model simulations for mutant EGFR corroborate the importance
of ubiquitin binding in the down-regulation of EGFR signaling. The various con-
sequences of ubiquitin binding in the EGFR trafficking observed through model
predictions redefine the role of receptor ubiquitination.
Considering the results obtained from model simulations, we propose that
receptor ubiquitination activates the clathrin independent endocytosis and initiates
surface as well as endosomal sorting responsible for the down-regulation of EGFR
trafficking. In conclusion, our model provides insights into the underlying dynam-
ics of dose-dependent EGFR trafficking and is able successfully explain the ex-
perimental observations. By adding various signaling pathways in it, our model
can be extended to study the effects of altered EGFR localization on the signaling.
This extended model can function as a framework that explains the dose-dependent
modulation of EGF induced signaling. The knowledge gained from the extended
model can be helpful in understanding how cells attenuate signaling and avoid over-
stimulation in order to escape cancer and other cell cycle related disorders.
Appendix A
Genetic algorithm
Genetic algorithms (GA) are the most popular evolutionary computational methods
known for being the most powerful and broadly applicable stochastic optimization
techniques (Gen and Cheng, 2000). GAs were invented and developed by John
Holland and his students between 1960s and 70s in University of Michigan. Basis
for the algorithm comes from the idea of natural selection observed during the evo-
lution of species. Concept behind the GA is to evolve a population of solutions to
any given problem using the operators responsible for inducing genetics variations
during the natural selections (Mitchell, 1996).
Inspiration from biology
Cells in any living organism carry chromosomes (strings of DNA) containing ge-
netic information of the organism. Each chromosome made up of small fragments
called genes that encodes for a proteins. During the sexual reproduction together
the two processes, crossover (or recombination) that causes exchange of genes be-
tween the two patents’ single chromosomes and mutation which is a copying error,
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introduce variations in the offspring’s genome. This variation comes at cost of fit-
ness, typically defined as the probability to survive and probability to reproduce.
GA mimics the sexual reproduction assuming a candidate solution to be the
chromosome and a gene as a single entity in the solution. Crossover is the exchange
of entities between different candidates and mutation denotes the random change in
the entity. In our case the candidate solution (or individual or chromosome) is a set
containing 13 values given to 13 unknown parameters that we intend to estimate
and a single parameter value in the set hence becomes a gene. Crossover mixes
different individuals and mutation modifies the value of parameters, introducing
variations in newly produced individuals. Fitness of every individual is estimated
using an objective function or a cost function. In our simulations objective func-
tion quantifies the difference between the solution provided by the individual and
the experimental observations. Fitness of an individual is inversely proportional to
the difference calculated by the objective function. Continuous cycle of crossover
and mutation produces more and more fit individuals, which pushes the solution to
the optimal value. Hence, factors governing the crossover and mutation in popula-
tion are important to insure a speedy optimization. A typical genetic algorithm has
following steps (Mitchell, 1996):
1. Generate a random population of desired size n as first guess.
2. Calculate the fitness for each individual in the population.
3. Continue the following process till offspring population reaches to n
(a) Select individual based on the fitness with fittest given the high selection
probability.
(b) Crossover the selected individuals at randomly chosen points to form
new offspring.
Genetic algorithm 68
(c) Mutate the offspring at a random location.
4. Replace the old population with the new offspring population.
5. Return to step 2 until an optimal solution is obtained.
In the computational language one iteration in the GA is called a generation and the
number of iterations vary depending on the requirements or based on the desired
optimal of an objective function. The entire set of generation is termed as a run. GA
is a stochastic algorithm hence each run may produce completely different solution
sets. Therefore, an average over multiple GA runs is more reliable than single run.
In the recent time the GAs improved to perform fast and converge in less iteration.
MATLAB global optimization toolbox offers a GA function, which can be accessed
to perform parameter estimation. We build our optimization code that calls the GA
function in the toolbox. Using the optimization code we obtained numerous best fit
solutions.
Optimization code in MATLAB
function mygacoderuninadvance
global datafil tot sur deg rec delow nh
%load data files
load sigismundetalfig1b.txt;
load sigismundetalfig1a.txt;
load sigismundetalfig3a.txt;
load sigismundetalfig5a.txt;
load sigismundetalfig4cLow.txt;
%parameter range file
load UbLb.txt
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%Lower bound[0.0010 0.5000 0.0010 0.0010 0.0010 0.0010
%0.0010 0.0010 0.0010 0.0010 0.0010 0.0010 0.0010]
%Upper bound[0.1500 1.0000 0.1500 0.1500 0.5000 0.7000
%0.1500 0.1500 0.1500 1.0000 0.5000 0.1500 0.5000]
%Reset the random number generator to CPU clock
RandStream.setDefaultStream(RandStream('mt19937ar','seed',...
sum(100*clock)));
sur=sigismundetalfig1b;
tot=sigismundetalfig1a;
deg=sigismundetalfig3a;
rec=sigismundetalfig5a;
delow=sigismundetalfig4cLow;
Lb=UbLb(1,:);
Ub=UbLb(2,:);
datafil=[sur; tot; deg; rec; 6 60; 6 40; 0 1; 0 1; 0 1; 0 1];
pops = 100;
gens = 500;
Elite=3;
iv=[Lb;Ub];
nh=2;
for i=1:100
options=...
gaoptimset('Display','off','Generations',gens,'StallGenLimit',...
20,'CrossoverFraction',0.8,'TolFun',1e-3,'PopulationSize',pops,...
'MutationFcn', {@mutationadaptfeasible},'PopInitRange',iv,...
'CrossoverFcn',{@crossoverscattered},'FitnessScalingFcn',...
{@fitscalingrank},...
'SelectionFcn',{@selectionstochunif},'EliteCount',Elite);
[p,fval,exitflag,output,final_pop,scores] =...
ga(@modelobj, 13,[],[],[],[],...
Lb,Ub,[],options);
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M=[i,p,fval];
dlmwrite('myresults.txt',M,'delimiter',...
'\t','precision',6,'-append');
z=strcat('advpset',num2str(i));
if(fval<180)
dlmwrite('mybestfits.txt',M,'delimiter',...
'\t','precision',6,'-append');
save(z);
end
end
end
%Objective function with constraints
function objective=modelobj(beta)
global datafil
xfil=datafil(:,1);
yfil=datafil(:,2);
yhatfil=mixmodelfil(beta,xfil);
objective=sum((yhatfil(1:10)-yfil(1:10)).ˆ2)...
+sum((yhatfil(16:19)-yfil(16:19)).ˆ2)...
+sum((yhatfil(11:12)-yfil(11:12)).ˆ2)...
+sum((yhatfil(14:15)-yfil(14:15)).ˆ2);
if (yhatfil(20)<60)
objective=1e6;
end
if (yhatfil(21)>40)
objective=1e6;
end
if (yhatfil(22)>yhatfil(23))
objective=1e6;
end
if (yhatfil(24)>yhatfil(25))
objective =1e6;
end
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if (yhatfil(26)>31)
objective = 1e6;
end
if (yhatfil(27)<80)
objective = 1e6;
end
if(yhatfil(28)<60)
objective = 1e6;
end
if(yhatfil(29)>20)
objective=1e6;
end
end
%Calculation of simulated data for objective function
function yhat=mixmodelfil(beta1,x)
Vx=1e-10;
Ve=1e-14;
Nav=6.02214E23;
R0=4.5e5;
%Total and Surface EGFR
L0=15.771;
I=zeros(17,1);
I(1)=L0;
I(2)=R0;
t1=x(1:6);
t2=x(7:10);
[T,Y] = ode15s(@devcelleqsfil,t1,I,[],beta1);
sur=100.*(Y(:,3)+Y(:,4)+Y(:,2))./R0;
[T1,Y1] = ode15s(@devcelleqsfil,t2,I,[],beta1);
total=100.*(Y1(:,3)+Y1(:,4)+Y1(:,2)+...
Y1(:,5)+Y1(:,6)+Y1(:,7)...
+Y1(:,8)+Y1(:,9)+Y1(:,10)+Y1(:,17))./R0;
%EGF degradation
L0=3.155;
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R0=4.4e5;
t1=[0 6];
t2=[0; x(11:15)];
I=zeros(17,1);
I(1)=L0;
I(2)=R0;
%Pulse phase
[T,Y] = ode15s(@devcelleqsfil,t1,I,[],beta1);
I2=Y(end,:);
inito=(I2(5)+I2(7)+I2(11)+I2(14)+I2(6)+I2(8)+...
I2(12)+I2(15));
intc=100*(I2(5)+I2(7)+I2(11)+I2(14))/inito;
intn=100*(I2(6)+I2(8)+I2(12)+I2(15))/inito;
I2(1:4)=0;
%Chase phase
[T1,Y1] = ode15s(@devcelleqsfil,t2,I2,[],beta1);
Int=Y1(:,5)+Y1(:,6)+Y1(:,7)+Y1(:,8)+Y1(:,11)...
+Y1(:,12)+Y1(:,14)+Y1(:,15)...
+(Nav*Vx).*Y1(:,1);
deg=Y1(:,14)+Y1(:,15);
pdeg=100.*deg(2:end)./Int(2:end);
pdc=sum(Y1(1:end,14)./(I2(5)+I2(7)+I2(11)+I2(14)));
pdn=sum(Y1(1:end,15)./(I2(6)+I2(8)+I2(12)+I2(15)));
pdrc=sum(Y1(1:end,13)./(I2(5)+I2(7)+I2(9)+I2(13)));
pdrn=sum(Y1(1:end,16)./(I2(6)+I2(8)+I2(10)+I2(16)));
pdce=100*Y1(end,14)./(I2(5)+I2(7)+I2(11)+I2(14));
pdne=100*Y1(end,15)./(I2(6)+I2(8)+I2(12)+I2(15));
%Recycling of EGF
%Pulse phase
[T,Y] = ode15s(@devcelleqsfil,[0 15],I,[],beta1);
I2=Y(end,:);
I2(1:4)=0;
I2;
%Chase phase
[T1,Y1] = ode15s(@devcelleqsfil,[0; x(16:19)],I2,[],beta1);
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Y1;
wq=I2(5)+I2(7)+I2(11)+I2(14);
we=(Y1(end,5)+Y1(end,7)+Y1(end,11)+Y1(end,14));
prce=100*((I2(5)+I2(7)+I2(11)+I2(14))-(Y1(end,5)+...
Y1(end,7)+Y1(end,11)...
+Y1(end,14)))./(I2(5)+I2(7)+I2(11)+I2(14));
prne=100*((I2(6)+I2(8)+I2(12)+I2(15))-(Y1(end,6)+...
Y1(end,8)+Y1(end,12)...
+Y1(end,15)))./(I2(6)+I2(8)+I2(12)+I2(15));
Int=Y1(:,5)+Y1(:,6)+Y1(:,7)+Y1(:,8)+Y1(:,11)...
+Y1(:,12)+Y1(:,14)+Y1(:,15)...
+(Nav*Vx).*Y1(:,1);
rec=(Nav*Vx).*Y1(:,1)+Y1(:,3)+Y1(:,4);
prec=100.*rec(2:end)./Int(2:end);
yhat=[sur;total;pdeg;prec; intc; intn; pdc;...
pdn; pdrc; pdrn; pdce; pdne;...
prce; prne];
end
%Model equations
function dy=devcelleqsfil(t,y,beta1)
global nh
dy=zeros(17,1);
Vx=1e-10;
Ve=1e-14;
R0=4.5e5;
Nav=6.02214E23;
kb=0.063;
kub=0.16;
kp=4.9722;
ku=beta1(1)*((y(1))ˆnh)/((1.0)ˆnh+(y(1))ˆnh);
kun=0.0;
ken=beta1(2);
kec=beta1(3);
kee=beta1(4);
keb=0.0085;
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keub=0.66;
krc=beta1(5);
krn=beta1(6);
klc=beta1(7);
kln=beta1(8);
kdrc=beta1(9);
kdrn=beta1(10);
kdlc=beta1(11);
kdln=beta1(12);
kun=0.0;
kdub=beta1(13);
dy(1)=(-kb*y(1)*y(2)+kub*y(3)+klc*y(11)+kln*y(12))/(Nav*Vx);%Lm
dy(2)=-kb*y(1)*y(2)+kub*y(3)+krc*y(9)+krn*y(10);%Rs
dy(3)=kb*y(1)*y(2)-kub*y(3)-kec*y(3)-ku*y(3)+krc*y(7)+kun*y(4);%Cs
dy(4)=ku*y(3)-ken*y(4)-kun*y(4)+krn*y(8);%Cu
dy(5)=kec*y(3)-kee*y(5);%Cic
dy(6)=ken*y(4)-kee*y(6);%Cin
dy(7)=kee*y(5)-keub*y(7)+keb*y(9)*y(11)/(Nav*Ve)-krc*y(7);%Cec
dy(8)=kee*y(6)-keub*y(8)+keb*y(10)*y(12)/(Nav*Ve)-krn*y(8);%Cen
dy(9)=keub*y(7)-keb*y(9)*y(11)/(Nav*Ve)-krc*y(9)-kdrc*y(9);%Rec
dy(10)=keub*y(8)-keb*y(10)*y(12)/(Nav*Ve)-krn*y(10)-kdrn*y(10);%Ren
dy(11)=keub*y(7)-keb*y(9)*y(11)/(Nav*Ve)-klc*y(11)-kdlc*y(11);%Lec
dy(12)=keub*y(8)-keb*y(10)*y(12)/(Nav*Ve)-kln*y(12)-kdln*y(12);%Len
dy(13)=kdrc*y(9);%Rdc
dy(14)=kdlc*y(11);%Ldc
dy(15)=kdln*y(12);%Ldn
dy(16)=kdub*y(17);%Rdn
dy(17)=kdrn*y(10)-kdub*y(17);%Rdu
end
Appendix B
Identifiability analysis
Idea behind the identifiability analysis is to investigate whether or not a unique so-
lution for the unknown parameters of interest can be found using the available data.
Volume of data available represent the amount of information at hand and quality
indicates reliability of the data. Hence, for the purpose of parameter estimation
knowledge about the quality and quantity of any available data is important.
Fisher information matrix
The Fisher information matrix (FIM) is a measure of the amount of information
available in the data about the unknown parameters (Cobelli and DiStefano, 1980;
Goodwin and Payne, 1977). Thus it is closely related to the identifiability of the
parameters. Optimization can be defined as the process of minimizing the objective
function, which can be defined as follows (Englezos, 2001) also defined in docu-
mentation of SensSB toolbox.
S(p) =
N∑
i=1
((yˆi − yi(p))
TQi(yˆij − yij(p)) (B.1)
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The expected value of the objective function for a differential change in the param-
eter from the optimal is given by:
E[S(p+ δp)] ∼= δpT
[
N∑
i=1
(
∂yi
∂p
)T
Qi
(
∂yi
∂p
)]
δp+
N∑
i=1
tr(CiQi) (B.2)
where, Ci represents the measurement error covariance matrix (typicallyQi is cho-
sen as C−1i ). In our case we use a unweighted least square hence Qi is unity ma-
trix. In order to minimize the objective function the term in the [·] should be posi-
tive. This termed is called the Fisher information matrix of the estimation problem
(Rehm and Reed, 2001).
FIM =
N∑
i=1
(
∂yi
∂p
)T
Qi
(
∂yi
∂p
)
(B.3)
Here, the term ∂yi/∂p denotes the output sensitivity of variable yi with respect to
variations in parameter p . Non-singularity of the information matrix is regarded
as the necessary and sufficient condition for identifiability of the systems (Good-
win and Payne, 1977; Cobelli and DiStefano, 1980). If the sensitivity equations
show a linear dependence then FIM will become singular leading to unidentifiabil-
ity (Rodriguez-Fernandez et al., 2006; Rehm and Reed, 2001).
Covariance matrix
The Fisher information matrix is also an approximation of the inverse of the param-
eter estimation error covariance matrix of the best linear unbiased estimator (Rehm
and Reed, 2001).
C = FIM−1 =
[
N∑
i=1
(
∂yi
∂p
)T
Qi
(
∂yi
∂p
)]−1
(B.4)
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Correlation matrix
A correlation matrix provides information about the inter-relation between the es-
timated parameters. In this matrix the elements are the approximate correlation
coefficients between two parameters and can be estimated from the Covariance ma-
trix as follows (Miao et al., 2011):
rij =
Cij√
CiiCjj
, i )= j, (B.5)
rij = 1, i = j (B.6)
Here, rij is the correlation coefficient between parameter pi and pj . If there exists a
strong correlation between two parameters estimate pi and pj , values of rij is close
to 1, parameters pi and pj are said to be indistinguishable. A strong correlation
between the parameters indicates that the two parameters are strongly dependent on
each other and hence cannot be separately estimated (Miao et al., 2011). A singular
FIM indicates the presence of strong correlation between the parameters where the
value of rij is greater than 0.99 (Rodriguez-Fernandez et al., 2006). In SensSB
toolbox correlation coefficient of 0.95 and above is recommended as strong and if
such strong correlation exists then systems is termed as unidentifiable.
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